BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 7907895)

  • 21. A comparison of the cholinergic activity of selected H2-antagonists and sulfoxide metabolites.
    Kosh JW; Sowell JW; Chapman JM
    Pharm Res; 1989 Aug; 6(8):709-13. PubMed ID: 2573049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of cimetidine, ranitidine, and famotidine on human neutrophil functions.
    Mikawa K; Akamatsu H; Nishina K; Shiga M; Maekawa N; Obara H; Niwa Y
    Anesth Analg; 1999 Jul; 89(1):218-24. PubMed ID: 10389808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effects of H2-receptor antagonists on platelet function in vitro.
    Nakamura K; Kariyazono H; Shinkawa T; Yamaguchi T; Yamashita T; Ayukawa O; Moriyama Y; Yotsumoto G; Toyohira H; Taira A; Yamada K
    Hum Exp Toxicol; 1999 Aug; 18(8):487-92. PubMed ID: 10462360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histamine-2 receptor antagonists do not alter serum ethanol levels in fed, nonalcoholic men.
    Raufman JP; Notar-Francesco V; Raffaniello RD; Straus EW
    Ann Intern Med; 1993 Apr; 118(7):488-94. PubMed ID: 8095127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
    Ohsawa T; Hirata W; Higichi S
    Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoprotective action of roxatidine acetate HCl.
    Shiratsuchi K; Fuse H; Hagiwara M; Mikami T; Miyasaka K; Sakuma H
    Arch Int Pharmacodyn Ther; 1988; 294():295-304. PubMed ID: 2906796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further evidence for an interaction between alcohol and certain H2-receptor antagonists.
    Guram M; Howden CW; Holt S
    Alcohol Clin Exp Res; 1991 Dec; 15(6):1084-5. PubMed ID: 1686371
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of immunomodulative effects of the histamine-2 receptor antagonists cimetidine, ranitidine, and famotidine on peripheral blood mononuclear cells in gastric cancer patients.
    Hahm KB; Kim WH; Lee SI; Kang JK; Park IS
    Scand J Gastroenterol; 1995 Mar; 30(3):265-71. PubMed ID: 7770717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of famotidine with cimetidine and ranitidine.
    Berardi RR; Tankanow RM; Nostrant TT
    Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholinergic effects of histamine-H2 receptor antagonists partly through inhibition of acetylcholinesterase.
    Aono M; Moriga M; Mizuta K; Narusawa H
    Gastroenterol Jpn; 1986 Jun; 21(3):213-9. PubMed ID: 2874096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antisecretory and antiulcer effect of the H2-receptor antagonist famotidine in the rat: comparison with ranitidine.
    Scarpignato C; Tramacere R; Zappia L
    Br J Pharmacol; 1987 Sep; 92(1):153-9. PubMed ID: 2889492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
    Nwokolo CU; Smith JT; Sawyerr AM; Pounder RE
    Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histamine H2-antagonists modify gastric emptying in the rat.
    Bertaccini G; Scarpignato C
    Br J Pharmacol; 1982 Nov; 77(3):443-8. PubMed ID: 6128042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rebound hypersecretion after H2-antagonist withdrawal--a comparative study with nizatidine, ranitidine and famotidine.
    Fullarton GM; Macdonald AM; McColl KE
    Aliment Pharmacol Ther; 1991 Aug; 5(4):391-8. PubMed ID: 1685675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
    Lin JH
    Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of histamine-2 receptor antagonists on blood alcohol levels: a meta-analysis.
    Weinberg DS; Burnham D; Berlin JA
    J Gen Intern Med; 1998 Sep; 13(9):594-9. PubMed ID: 9754514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.
    Dammann HG; Gottlieb WR; Walter TA; Dreyer M; Müller P; Simon B; Keohane P
    Hepatogastroenterology; 1986 Oct; 33(5):217-20. PubMed ID: 2879782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of the animal pharmacology of roxatidine acetate.
    Scholtholt J; Bickel M; Herling AW
    Drugs; 1988; 35 Suppl 3():30-40. PubMed ID: 2905247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of H2-receptor blockers on response of cerebral blood flow to normocapnic hypoxia.
    Audibert G; Saunier C; Hartemann D; Bigard O; Haberer JP
    Anesth Analg; 1991 Apr; 72(4):532-7. PubMed ID: 1672490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists.
    Ahmadi A; Ebrahimzadeh MA; Ahmad-Ashrafi S; Karami M; Mahdavi MR; Saravi SS
    Fundam Clin Pharmacol; 2011 Feb; 25(1):72-9. PubMed ID: 20070855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.